Another commonly prescribed generic in the US has fallen to shortages, as the country battles with a particularly fierce winter flu season.
Following shortages across the US for generic versions of two highly prescribed medicines, Adderall (mixed amphetamine salts) and the antibiotic amoxicillin, another is now in short supply – oseltamivir, or Tamiflu, the antiviral used to treat and prevent influenza A and influenza B.
According to the American Society of Health-System Pharmacists, several key generics manufacturers, including Teva and Zydus Cadila, have reported
Adalvo and Gedeon Richter have announced a global co-development deal for semaglutide for obesity. Adalvo CEO Anil Okay spoke to Generics Bulletin about the alliance as well as the broader competitive landscape for GLP-1s.
After receiving a favorable court ruling last year, Lupin has secured its first-place spot for generic tolvaptan tablets in the US.
The UK generics and biosimilars industry will now be represented by Medicines UK, the new name for the former British Generic Manufacturers Association.
Generic competition to AstraZeneca’s blockbuster SGLT2 inhibitor Forxiga (dapagliflozin) treatment for diabetes may hit England and Wales earlier than 2028 after a pair of SPCs were invalidated following proceedings initiated by a trio of generics manufacturers.
